Literature DB >> 29859870

Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue.

Ruth Alonso1, Ana M Fernández-Fernández1, Diana Pisa1, Luis Carrasco2.   

Abstract

Multiple sclerosis (MS) is the prototypical inflammatory disease of the central nervous system (CNS), leading to multifocal demyelination and neurodegeneration. The etiology of this incurable disease is unknown and remains a matter of intensive research. The possibility that microbial infections, such as viruses or bacteria, can trigger an autoimmune reaction in CNS tissue has been suggested. However, the recent demonstration that bacteria are present in CNS tissue points to a direct involvement of microbial infections in the etiology of MS. In the present study, we provide the first evidence of fungal infection in CNS tissue of MS patients, and demonstrate that fungal DNA from different species can be detected in the CNS. We used, nested PCR assays together with next-generation sequencing to identify the fungal species in the nervous tissue of 10 patients with MS. Strikingly, Trichosporon mucoides was found in the majority of MS patients, and particularly high levels of this fungus were found in two patients. Importantly, T. mucoides was not detected in the CNS of control subjects. We were also able to visualize fungal structures in CNS tissue sections by immunohistochemistry using specific antifungal antibodies, which also revealed the accumulation of a number of microbial cells in microfoci. Again, microbial structures were not observed in CNS sections from controls. In addition to fungi, neural tissue from MS patients was also positive for bacteria. In conclusion, our present observations point to the novel concept that MS could be caused by polymicrobial infections. Thus, mycosis of the CNS may be accompanied by opportunistic bacterial infection, promoting neuroinflammation and directly causing focal lesions, followed by demyelination and axonal injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria and fungal co-infections; Fungal infection; Multiple sclerosis; Next generation sequencing; Polymicrobial infection

Mesh:

Year:  2018        PMID: 29859870     DOI: 10.1016/j.nbd.2018.05.022

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

1.  Malassezia in the central nervous system and multiple sclerosis.

Authors:  Julián Benito-León; Martin Laurence
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

Review 2.  A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis.

Authors:  Domenico Plantone; Matilde Inglese; Marco Salvetti; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2019-01-14       Impact factor: 4.003

3.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

Review 4.  Overview of the Potential Role of Malassezia in Gut Health and Disease.

Authors:  Madeleine Spatz; Mathias L Richard
Journal:  Front Cell Infect Microbiol       Date:  2020-05-26       Impact factor: 5.293

5.  Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson's disease individuals.

Authors:  Janis R Bedarf; Naiara Beraza; Hassan Khazneh; Ezgi Özkurt; David Baker; Valeri Borger; Ullrich Wüllner; Falk Hildebrand
Journal:  Microbiome       Date:  2021-03-26       Impact factor: 14.650

6.  Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.

Authors:  Fumitaka Sato; Yumina Nakamura; Aoshi Katsuki; Sundar Khadka; Ijaz Ahmad; Seiichi Omura; Nicholas E Martinez; Ikuo Tsunoda
Journal:  Front Cell Infect Microbiol       Date:  2022-02-07       Impact factor: 5.293

Review 7.  The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges.

Authors:  Pei Yee Tiew; Micheál Mac Aogain; Nur A'tikah Binte Mohamed Ali; Kai Xian Thng; Karlyn Goh; Kenny J X Lau; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

8.  Brain Microbiota in Huntington's Disease Patients.

Authors:  Ruth Alonso; Diana Pisa; Luis Carrasco
Journal:  Front Microbiol       Date:  2019-11-12       Impact factor: 5.640

9.  Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.

Authors:  Tatiana Koudriavtseva; Annunziata Stefanile; Marco Fiorelli; Caterina Lapucci; Svetlana Lorenzano; Silvana Zannino; Laura Conti; Giovanna D'Agosto; Fulvia Pimpinelli; Enea Gino Di Domenico; Chiara Mandoj; Diana Giannarelli; Sara Donzelli; Giovanni Blandino; Marco Salvetti; Matilde Inglese
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

Review 10.  Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease.

Authors:  Rodolfo Kölliker-Frers; Lucas Udovin; Matilde Otero-Losada; Tamara Kobiec; María Inés Herrera; Jorge Palacios; Gabriela Razzitte; Francisco Capani
Journal:  Mediators Inflamm       Date:  2021-05-31       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.